Johnson & Johnson
Feds Should Break Up Amazon
Amazon's dominance in a growing array of marketplaces could have catastrophic effects.
J&J, Aetna CEOs Hit Fee-for-Service System
The chief executives of two health-care giants want the industry to move further toward payments based on quality of care.
Finance Chiefs Praise Deloitte’s CFO Academy
Participants and the CFOs who send them to the program express passion for the development of future finance leaders.
What Makes for a Public-Company CFO?
Five top finance chiefs tell how they got where they are, and what their potential successors need to do.
J&J Posts $17.7B in Revenue, Misses Estimates
Tepid growth in pharmaceuticals and consumer products held back first-quarter sales but the company is still confident it will meet its full-year guidance.
J&J Boosts Drug Roster With $30B Actelion Deal
The largest acquisition in J&J's history gives it access to Actelion's portfolio of high-margin treatments for rare diseases.
J&J Sales Increase 1.7% But Miss Estimates
Earnings jumped 19% to $3.81 billion in the fourth quarter, but sales were hit by slowing demand for medical devices.
Johnson & Johnson Buys Vogue International
J&J buys shampoo and hair styling products firm for $3.3 billion.
J&J Makes a Sweet Deal to Sell Splenda
Since J&J introduced it in 1999, Splenda has reached $300 million in annual sales.
Link Between Health-Care Quality and Stock Price?
A new study suggests there may be such a relationship. Also: exclusive interviews on the financial impact of good health care with Johnson & Johnson’s CFO and the ex-CEO of Pitney Bowes.
Tax Rates: the Haves and Have Nots
Comparing corporate tax rates can be hard, given all the tax terminology that's out there. But a new study reveals what real rates companies are paying.